Research ArticleClinical Studies
The Role of Previous Therapies and Sites of Metastasis as Influencing Factors on Discordance of ER, PR and HER2 Status Between Primary and Metastasized Breast Cancer
CONSTANZE VOGEL, WOLFRAM MALTER, BERND MORGENSTERN, SEBASTIAN LUDWIG, JÖRG JANNE VEHRESCHILD, STEFANIE HAMACHER, PETER MALLMANN, VERENA KIRN and FABINSHY THANGARAJAH
Anticancer Research May 2019, 39 (5) 2647-2659; DOI: https://doi.org/10.21873/anticanres.13389
CONSTANZE VOGEL
1Department of Obstetrics and Gynecology, Medical Faculty, University Hospital of Cologne, Cologne, Germany
WOLFRAM MALTER
1Department of Obstetrics and Gynecology, Medical Faculty, University Hospital of Cologne, Cologne, Germany
BERND MORGENSTERN
1Department of Obstetrics and Gynecology, Medical Faculty, University Hospital of Cologne, Cologne, Germany
SEBASTIAN LUDWIG
1Department of Obstetrics and Gynecology, Medical Faculty, University Hospital of Cologne, Cologne, Germany
JÖRG JANNE VEHRESCHILD
2Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany
3German Centre for Infection Research, partner-site Bonn-Cologne, Cologne, Germany
STEFANIE HAMACHER
4Department of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany
PETER MALLMANN
1Department of Obstetrics and Gynecology, Medical Faculty, University Hospital of Cologne, Cologne, Germany
VERENA KIRN
5Department of Senology, Heilig Geist Krankenhaus, Cologne, Germany
FABINSHY THANGARAJAH
1Department of Obstetrics and Gynecology, Medical Faculty, University Hospital of Cologne, Cologne, Germany
In this issue
The Role of Previous Therapies and Sites of Metastasis as Influencing Factors on Discordance of ER, PR and HER2 Status Between Primary and Metastasized Breast Cancer
CONSTANZE VOGEL, WOLFRAM MALTER, BERND MORGENSTERN, SEBASTIAN LUDWIG, JÖRG JANNE VEHRESCHILD, STEFANIE HAMACHER, PETER MALLMANN, VERENA KIRN, FABINSHY THANGARAJAH
Anticancer Research May 2019, 39 (5) 2647-2659; DOI: 10.21873/anticanres.13389
The Role of Previous Therapies and Sites of Metastasis as Influencing Factors on Discordance of ER, PR and HER2 Status Between Primary and Metastasized Breast Cancer
CONSTANZE VOGEL, WOLFRAM MALTER, BERND MORGENSTERN, SEBASTIAN LUDWIG, JÖRG JANNE VEHRESCHILD, STEFANIE HAMACHER, PETER MALLMANN, VERENA KIRN, FABINSHY THANGARAJAH
Anticancer Research May 2019, 39 (5) 2647-2659; DOI: 10.21873/anticanres.13389
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.